tiprankstipranks
Capha Pharmaceuticals Inc. (FPSUF)
OTHER OTC:FPSUF
US Market

Capha Pharmaceuticals (FPSUF) Income Statement

Compare
1 Followers

Capha Pharmaceuticals Income Statement

Last quarter (Q3 2024), Capha Pharmaceuticals's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Capha Pharmaceuticals's net income was C$-11.59K. See Capha Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
-----
Operating Expenses
C$ 53.00KC$ 57.68KC$ 44.49KC$ 50.23KC$ 64.71K
Depreciation and Amortization
-----
EBITDA
C$ -53.22KC$ -57.68KC$ -44.49KC$ -50.23KC$ -64.61K
Operating Income
C$ -53.14KC$ -57.89KC$ -44.80KC$ -50.71KC$ -65.39K
Other Income/Expenses
C$ -222.00C$ -414.00C$ -5.00C$ -450.00C$ 101.00
Pretax Income
C$ -53.36KC$ -58.31KC$ -44.81KC$ -51.16KC$ -65.29K
Net Income
C$ -53.36KC$ -58.31KC$ -44.81KC$ -51.16KC$ -65.29K
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Diluted EPS
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Weighted Average Shares Outstanding
64.48M 64.43M 64.43M 64.43M 64.43M
Weighted Average Shares Outstanding (Diluted)
64.43M 64.43M 64.43M 64.43M 64.43M
Currency in CAD

Capha Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis